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Abstract
Background: Ixeris dentata Nakai has been used for the treatment of mithridatism, calculous, indigestion,
pneumonia, hepatitis, and tumors in Korea, China, and Japan. However, the effect of a water extract of Ixeris dentata
(ID) and its molecular mechanism on allergic inflammation has not been elucidated. In this study, we attempted to
evaluate the effects of ID and its major compound caffeic acid on allergic inflammation in vivo and in vitro.
Methods: ID was applied to 2, 4-dinitrofluorobenzene (DNFB)-induced atopic dermatitis (AD)-like skin lesion mice
and immune cell infiltration, cytokine production, and the activation of mitogen-activated protein kinases (MAPKs)
were investigated. Moreover, the effect of ID on compound 48/80-induced anaphylactic shock was investigated in a
mouse model. The human keratinocyte cell line (HaCaT cells) and human mast cells (HMC-1) were treated with ID
or caffeic acid to investigate the effects on the production of chemokines and proinflammatory cytokines and on
the activation of MAPKs.
Results: ID inhibited the serum levels of IgE and interleukin (IL)-1β in DNFB-induced AD-like skin lesion mouse
models and suppressed anaphylactic shock in the mouse models. ID and caffeic acid inhibited the production of
chemokines and adhesion molecules in HaCaT cells. In addition, ID reduced the release of tumor necrosis factor-α
and IL-8 via the inhibition of MAPKs phosphorylation in HMC-1 cells.
Conclusions: These results suggest that ID is a potential therapeutic agent for allergic inflammatory diseases,
including dermatitis.
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Background
Atopic dermatitis (AD), also known as atopic eczema, is a
common, chronic and allergic inflammatory skin disease
[1]. The worldwide prevalence rate of AD is nearly 10-20 %
in children and 1–3 % in adults. Genetic and environmen-
tal factors are important causes in many AD patients [2].
Immune system disorders cause AD, which is related to
several types of cells (T lymphocytes, macrophages, mast
cells, and keratinocytes), specifically T helper (Th) cell dys-
function and IgE production [3, 4].
Ixeris dentata Nakai (Compositae) has been used for the
treatment of mithridatism, calculous, indigestion, pneu-
monia, hepatitis, and tumors in Korea, China, and Japan
[5]. It has been reported that Ixeris dentata has neuropro-
tective effects [6], anti-diabetic effects [7], protection
effects against colitis and skin inflammation [8, 9], and anti-
allergic effects [10, 11]. In this study, the effect of the Ixeris
dentata water extract (ID) on allergic inflammatory reac-
tions via MAPKs signaling was investigated in human kerati-
nocytes and human mast cells and was also assessed in vivo.
Keratinocytes, which are the main type of epidermal cells,
play a key role in the pathogenesis of AD [12]. Epidermal
keratinocytes release various inflammatory mediators, such
* Correspondence: jyum@khu.ac.kr; jooklim@wku.ac.kr
†Equal contributors
3College of Korean Medicine, Institute of Korean Medicine, Kyung Hee
University, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul, Republic of Korea
1Department of Oriental Pharmacy, College of Pharmacy, Wonkwang-Oriental
Medicines Research Institute, Wonkwang University, Jeonbuk 570-749,
Republic of Korea
Full list of author information is available at the end of the article
© 2015 Jeon et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium,
provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Jeon et al. BMC Complementary and Alternative Medicine  (2015) 15:196 
DOI 10.1186/s12906-015-0700-x
as chemokines and adhesion molecules by tumor necrosis
factor (TNF)-α and interferon (IFN)-γ stimulations [13,
14]; these factors are involved in the development of in-
flammatory skin diseases, including AD. Thymus and
activation-regulated chemokine (TARC or CCL17) as well
as macrophage-derived chemokine (MDC or CCL22),
which are Th2 chemokines, mediate the migration of lym-
phocytes to inflammatory sites and aggravate AD [15].
Additionally, the levels of TARC and MDC are elevated in
serum and skin lesions of AD patients [16, 17].
Mast cells are hematopoietic cells that originate from
progenitor cells in the bone marrow. They are considered
as key effector cells in IgE-mediated immediate hypersen-
sitivity and allergic disorders [18]. In response to various
stimuli, mast cells secrete a variety of bioactive substances,
such as histamine and several proinflammatory cytokines,
including interleukin (IL)-8 and TNF. These mediators
contribute to inflammation through the recruitment and
activation of immune cells [19]. Mast cells are increased in
a majority of AD patients and are believed to be involved
in the pathogenesis of AD [20].
Nuclear factor-kappaB (NF-κB) plays a pivotal role in
the regulation of immune and inflammatory responses
through the expression of cytokine, chemokine, and adhe-
sion molecules. When IκB proteins are phosphorylated
and degraded after stimulation, NF-κB is translocated into
the nucleus and initiates the transcription of genes that
are crucial in the development of inflammatory diseases.
Therefore, the activation of NF-κB is important in the pro-
gression of allergic inflammation [21–23].
Mitogen-activated protein kinases (MAPKs) signaling
pathway controls a vast array of physiological processes. In
multicellular organisms, there are three well-characterized
subfamilies of MAPKs. These MAPKs include the
extracellular signal-regulated kinases (ERKs); the c-jun
N-terminal kinases (JNKs); and the p38 MAPKs [24]. It
has shown to be important in the proliferation, activa-
tion, degranulation, and migration of various immune
cells. The activation of MAPKs is associated with the
allergic inflammatory response via the translocation of
NF-κB, which causes the production of proinflamma-
tory cytokines and chemokines [25–27]. Synthetically,
the inhibition of NF-κB and MAPKs activation has
been suggested as an anti-inflammatory strategy in al-
lergic inflammation.
In this study, we evaluated the effect of ID on DNFB-
induced AD-like skin lesion and anaphylactic shock in
mouse models. We also examined the inhibitory effects of
ID and its major compound, caffeic acid, on the produc-
tions of TNF-α/IFN-γ-induced chemokines and adhesion
molecules in the human keratinocyte HaCaT cell line.
Moreover, the effects of ID and caffeic acid on phorbol 12-
myristate 13-acetate (PMA)/calcium ionophore A23187
(A23287)-induced proinflammatory cytokines productions




2, 4-dinitrofluorobenzene (DNFB), compound 48/80, 3-(4,
5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide
(MTT), PMA, and A23187 were purchased from Sigma-
Aldrich Chemical Co. (St. Louis, MO, USA). Avidin perox-
idase (AP), fetal bovine serum (FBS), Roswell Park Memorial
Institute (RPMI) 1640, and Iscove's Modified Dulbecco's
Medium (IMDM) were purchased from Gibco BRL
(Grand Island, NY, USA). Anti-human TNF-α/IL-6/IL-8,
recombinant TNF-α/IL-6/IL-8, biotinylated TNF-α/IL-
6/IL-8, anti-mouse IgE/IL-1β, recombinant IgE, IL-1β,
biotinylated IgE, and IL-1β were purchased from BD
Pharmingen (San Diego, CA, USA). Anti-phospho p38
antibody was purchased from Cell Signaling Technol-
ogy, Inc. (Danvers, MA, USA). Anti-phospho ERK,
JNK, IκBα, anti-p38, JNK, NF-κB, histone, and GAPDH
antibodies were purchased from Santa Cruz Biotech-
nology, Inc. (Santa Cruz, CA, USA). Anti-ERK, and α-
tubulin antibodies were purchased from Bioworld
Technology (Minneapolis, MN, USA).
Animals
BALB/c mice (5 weeks, male, 19–20 g) were purchased
from Da-Mool science (Daejeon, Republic of Korea). The
animals were housed in a laminar air-flow room main-
tained at a temperature of 22 ± 1 °C and a reactive humid-
ity level of 55 ± 1 % throughout the study. All animal
experimental processes were approved by the Wonkwang
University Institutional Animal Care and Use Committee
(Confirmation No. WKU14-34).
Preparation of ID
Ixeris dentata was obtained from the Wonkwang Institute
of Biomedical Engineering Research and authenticated
by Professor S. J. Park, College of Korean Medicine,
Wonkwang University. A voucher specimen (No. 05-
17-12) was deposited at the Herbarium of the College
of Pharmacy, Wonkwang University. It was prepared by
decocting a dried prescription of herbs with distilled water
for 3 h. The extract was filtered, lyophilized, and kept at
4 °C. The samples were dissolved in distilled water and
then filtered through a 0.22 μm syringe filter. The yield of
the dried extract from the starting materials was about
7.8 %. A caffeic acid content analysis revealed a concentra-
tion of 4 ± 0.00 mg/g (0.4 ± 0.00 %) [8].
DNFB-induced dermatitis
Experiments were performed according to a previously
described method [28]. The dorsal skin of BALB/c mice
(n = 7) was shaved by depilatory equipment before the
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experiment. The mice were sensitized with 100 μl of
0.15 % DNFB in an acetone olive oil (3: 1) or a vehicle
applied to the dorsal skin twice each week for six weeks.
ID (1 mg/kg) was orally administrated six weeks during
the experiment.
Histological analysis
Dermatitis skins samples were excised from the mice 24 h
after the final DNFB application and fixed with 10 % for-
maldehyde, embedded in paraffin wax, routinely processed
and then sectioned into 4-μm-thick slices. The skin sec-
tions were then stained with hematoxylin and eosin and
examined by light microscopy for the presence of edema
and for inflammatory cell accumulation.
Enzyme-linked immunosorbent assay (ELISA)
96-well plates were coated with capture antibodies over-
night at 4 °C. After washing with PBST, samples and cyto-
kine standards were added and incubated at 37 °C for 2 h.
The plates were washed and biotinylated antibodies were
added. The samples were then left for 2 h. After washing,
the plates were incubated with AP for 30 min in an incu-
bator set to a temperature of 37 °C. Finally, TBS substrate
solution was added and color development was measured
by a microplate reader at 405 nm.
Preparation of total cell lysates and nuclear extracts and
western blot analysis
Stimulated cells were rinsed with ice-cold PBS and lysed
using lysis buffer (iNtRon Biotech, Seoul, Republic of
Korea) for 1 h. Total cell lysates were centrifuged for
10 min at 4 °C, after which the supernatants were obtained.
Nuclear extracts were prepared using NE-PER Nuclear and
Cytoplasmic Extraction Reagents (Pierce Thermo Scien-
tific, Rockford, USA). After bicinchoninic acid (BCA)
protein quantification, the supernatant was mixed with a
2× sample buffer, boiled for 5 min, separated by 10 % SDS-
polyacrylamide gel electrophoresis, and then transferred to
nitrocellulose membranes. The membranes were blocked
with 10 % skim milk for 1 h and 30 min and incubated for
3 h with primary antibodies. They were then incubated
with secondary antibodies for 45 min. Protein bands were
detected using an ECL solution.
Anaphylactic shock
The mice (n = 5) were administrated intraperitoneal in-
jections of compound 48/80 (8 mg/kg). Control mice re-
ceived a vehicle (PBS) and ID (0.01 - 1 g/kg) was orally
administrated 1 h prior to the injection of compound
48/80. Mortality was monitored for 1 h after the induc-
tion of anaphylactic shock.
Cell culture
Human immortalized keratinocytes (HaCaT cells) in
RPMI 1640 supplemented with 10 % FBS, 100 units/ml
of penicillin, and 100 μg/ml of streptomycin were cul-
tured in a humidified atmosphere of 5 % CO2/95 % air
at 37 °C. The human mast cell line (HMC-1) were cul-
tured in IMDM supplemented with 10 % FBS, 100 units/
ml of penicillin, and 100 μg/ml of streptomycin in a hu-
midified atmosphere of 5 % CO2/95 % air at 37 °C.
Cell viability
An MTT assay was performed to investigate the cell tox-
icity of ID and caffeic acid. MTT solution (500 μg/ml)
was added, followed by incubation at 37 °C for 4 h. The
crystallized formazan was dissolved in DMSO and the
absorbance was measured at 540 nm by a microplate
reader.
Reverse-transcriptase polymerase chain reaction (RT-PCR)
Total RNA was isolated from HaCaT cells according to
the manufacturer's specifications using an easy-BLUE
RNA extraction kit (INtRON Biotech., Seoul, Republic
of Korea). Total RNA and oligo(dT)15 were heated to
75 °C for 5 min and then placed on ice for at least
1 min. Each sample was reverse-transcribed to cDNA
for 60 min at 42 °C using a cDNA synthesis kit. RT-PCR
was performed with 1 μl of a cDNA mixture with a final
volume of 20 μl with 10 pM of cytokine primers, i-
MAXTM ІІ DNA Polymerase (5 U/μl), a 10× PCR buffer
(300 mM Tris–HCl (pH 9.0); 300 mM salts containing K+
and NH4
+, with 20 mM Mg2+), a dNTP mixture (2.5 mM/
each), DEPC (diethylpyrocarbonate)-treated water. Ampli-
fication was conducted for 35 cycles, as follows: denatur-
ation at 94 °C for 30 s, annealing at 60 °C for 30 s, and
extension at 72 °C for 45 s. Products were separated by
electrophoresis on a 1.5 % agarose gel and visualized by
staining with ethidium bromide. The gels were certificated
using a CN-TFX device (Vilber Lourmat, Marne-la-Vallée,
France). The primer sequences are shown in Table 1.
Statistical analysis
The results are shown as a summary of the data from
three experiments and are presented as the mean ± SD.
A statistical evaluation of the results was performed by
the Student’s t-test. For all experiments, p < 0.05 was
considered to be significant.
Results
Effect of ID on DNFB-induced dermatitis and serum IgE
and IL-1β levels
The cutaneous application of DNFB was repeated to in-
duce AD-like skin lesion in BALB/c mice. As shown in
Fig. 1a, AD-like skin lesions were recovered in the group
administrated ID as compared to the DNFB-treated group
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(control). The dermatitis skins were stained with
hematoxylin and eosin (H&E) and evaluated by light mi-
croscopy. Marked accumulation of immune cells was ob-
served in the control group, whereas the ID treatment
inhibited hyperplasia (Fig. 1b). To evaluate the effects of ID
on the inflammatory mediator production, blood samples
were collected and analyzed using the ELISA method.
Serum IgE and IL-1β levels were reduced by ID adminis-
tration (0.4213 ± 0.02407 and 0.1956 ± 0.04152 ng/ml)
compared to the control group (0.6677 ± 0.02048 and
0.2633 ± 0.00392 ng/ml) (Fig. 1c and d). These results indi-
cated that the ID administration reduced dermal hyperpla-
sia through the inhibition of inflammatory cell infiltration
and inflammatory mediator production.
Effect of ID on the phosphorylation of MAPKs and
transcription factors in DNFB-induced skin lesions
The activation of MAPKs induces the production of pro-
inflammatory cytokines and is highly activated in allergic
reactions, including dermatitis [25]. Therefore, we evalu-
ated the effect of ID on the phosphorylation of MAPKs.
An ID treatment suppressed the phosphorylation of
ERK, JNK, and p38 in dorsal skin compared to the con-
trol group (Fig. 2a). The relative expression levels of the
MAPKs are represented in Fig. 2b. Because NF-κB is a
pivotal transcription factor of inflammatory and immune
reactions [22], the effect of ID on the activation of NF-
κB was investigated. As shown in Fig. 2c, ID inhibited
the phosphorylation of IκBα and NF-κB translocation
into the nucleus. The relative expression levels of tran-
scription factors are represented in Fig. 2d. These results
suggest that ID inhibits the activation of MAPKs and
NF-κB in AD-like skin lesions.
Effect of ID on compound 48/80-induced anaphylactic
shock
The inhibitory effect of ID on anaphylactic shock pro-
duced by compound 48/80 was evaluated using BALB/c
Table 1 Sequences of the RT-PCR primers







Fig. 1 Effects of ID on DNFB-induced dermatitis and serum IgE and IL-1β levels. BALB/c mice (n = 7) were sensitized with 100 μl of 0.15 % DNFB
in an acetone-olive oil combination (3: 1) or a vehicle (acetone/olive oil = 3: 1) applied to the dorsal skin twice each week for a total period of six
weeks. ID (1 g/kg) was orally administrated to DNFB-treated mice for six weeks. (a) Comparison of DNFB-induced dermatitis in BALB/c mice after
oral administration of ID. (b) H&E stained tissue sections. Skin tissues were fixed with 10 % formaldehyde embedded in paraffin. (c and d) Blood
samples were collected from the mice, and the levels of serum IgE (c) and IL-1β (d) in the indicated groups were measured with the ELISA
method. Values represent the mean ± SD of independent experiments. . *p < 0.05, **p < 0.01
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mice. An oral administration of ID (0.01 - 1 g/kg) re-
duced the mortality rate induced by compound 48/80 in
a dose-dependent manner (Table 2).
Effects of ID and caffeic acid on the expression of
chemokines in HaCaT cells
Epidermal keratinocytes play multiple roles in the im-
mune reactions associated with allergic contact derma-
titis and atopic dermatitis skin diseases [12]. Therefore,
the effect of ID on the degree of cell viability was first
examined using an MTT assay. As shown in Fig. 3a,
treatment with 0.01 - 1 mg/ml ID did not show cytotox-
icity in HaCaT cells. To determine whether ID inhibits
the production of TNF-α/IFN-γ-induced chemokines,
we carried out a RT-PCR analysis and ELISA tests. The
expression levels of chemokines (IL-8, TARC, and
MDC), ICAM-1, and MMP-9 were suppressed by the ID
treatment (Fig. 3c). The relative mRNA expression levels
are represented in Fig. 3e. In previous research, we
found through an HPLC analysis that caffeic acid was a
major compound of ID [8]. Thus, we investigated the ef-
fect of caffeic acid on the production of cytokines and
chemokines in HaCaT cells. Concentrations of caffeic
acid were determined using MTT assay (Fig. 3b). Caffeic
acid decreased chemokines including IL-8, TARC and
MDC as well as ICAM-1 and MMP-9 expressions were
decreased by the caffeic acid treatment (Fig. 3d). The
relative mRNA expression levels are represented in
Fig. 3f.
Effects of ID on the production of proinflammatory
cytokines and the activation of MAPKs in HMC-1 cells
Mast cells play a role in allergic reactions through the
release of a number of mediators and cytokines [29]. We
determined whether ID regulates the levels of proinflam-
matory cytokines in HMC-1 cells. First, we checked the
cytotoxicity of ID on HMC-1 cells using an MTT assay
(Fig. 4a). In the activated HMC-1 cells, ID significantly
suppressed the production of TNF-α and IL-8, but not
IL-6 (Fig. 4b-d). Moreover, we investigated the regula-
tory effects of ID on the activation of MAPKs. ID
Fig. 2 Effects of ID on activation of MAPKs and NF-κB in skin lesions. Protein was isolated from normal or DNFB-induced dermatitis dorsal skin. (a)
Phosphorylation levels of ERK, JNK, and p38 was assayed by western blot analysis. (b) Relative levels of p-ERK, p-JNK, and p-p38 were calculated using
an image analyzer. Values represent the mean ± SD of independent experiments. (c) The phosphorylation of IκBα and the protein expressions
of NF-κB were assayed by western blot analysis. (d) The relative levels of p-IκBα and NF-κB were calculated using an image analyzer. Values
represent the mean ± SD of independent experiments. *p < 0.05, **p < 0.01
Table 2 Effect of ID on the compound 48/80-induced systemic
anaphylactic reaction
ID (g/kg)a Compound 48/80 (8 mg/kg)b Mortality (%)c





aThe groups of mice (n = 5) were orally administrated with saline or ID given at
various doses 1 h before the compound 48/80 injection
bThe compound 48/80 solution was intraperitoneally injected to the groups
of mice
cMortality (%) was presented as the ‘Number of dead mice × 100/Total number
of experimental mice’. This result was represented by average results from
three independent experiments
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decreased the PMA +A23187-induced phosphorylation
of p38 and ERK while the results for JNK showed no
changes (Fig. 4e). ID also inhibited the phosphorylation of
IκBα and the nuclear localization of NF-κB (Fig. 4f). These
results suggest that ID suppresses the activation of NF-κB
via p38 and ERK phosphorylation.
Effects of caffeic acid on the production of
proinflammatory cytokines and the activation of MAPKs
in HMC-1 cells
To investigate whether caffeic acid inhibits the produc-
tion of cytokines, the TNF-α, IL-8, and IL-6 levels were
measured by the ELISA method. The concentration of
caffeic acid in HMC-1 cells was determined by an MTT
assay (Fig. 5a). Caffeic acid significantly reduced the
levels of TNF-α and IL-8, but not IL-6 (Fig. 5b-d). We
examined the regulatory effects of caffeic acid on the
phosphorylation of MAPKs (p38, ERK, and JNK). Caffeic
acid decreased the PMA +A23187-induced phosphoryl-
ation of p38, while the results for ERK and JNK showed
no changes (Fig. 5e). Additionally, caffeic acid inhibited
the degradation of IκBα and the nuclear localization of
NF-κB (Fig. 5f ). These results suggest that caffeic acid
suppresses the activation of NF-κB via the inhibition of
p38 phosphorylation.
Discussion
AD is a chronic inflammatory skin disease associated with
cutaneous hyperreactivity to environmental triggers and
skin inflammatory responses driven by cytokines expres-
sion. Furthermore, the incidence of AD has continued to
increase over the past several decades [17]. Common
Fig. 3 Effects of ID and caffeic acid on the expression levels of inflammatory mediators in HaCaT cells. (a and b) HaCaT cells (2 × 105 cells/well)
were treated with ID (0.01 - 1 mg/ml) or caffeic acid (1–100 μM) for 12 h and the degree of cell viability was analyzed by an MTT assay. (c and d)
HaCaT cells (2 × 105 cells/well) were pre-treated with ID or caffeic acid for 30 min and were stimulated with TNF-α/IFN-γ for 18 h. The levels of
cytokine were assayed by a RT-PCR analysis. (e and f) Relative levels of IL-8, TARC, MDC, ICAM-1, and MMP-9 were calculated using an image
analyzer. Values represent the mean ± SD of three independent experiments. CA, caffeic acid. *p < 0.05, **p < 0.01
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treatments for AD are steroid therapy and immunosup-
pressive drugs, but these show side-effects, especially with
continuous application [30]. Therefore, researchers have
attempted to find a new drug in complementary and alter-
native medicines, such as herbal medicines [31, 32]. In this
study, we demonstrated the regulatory effect of ID on al-
lergic reactions in vivo and in vitro.
Haptens such as DNFB are used to induce a model of
murine-contact hypersensitivity (MCH). It has been
reported that MCH can generate AD-like skin lesions
and immune responses with Th1-and/or Th2-type
inflammation under certain conditions [33]. Dermatitis
is characterized as a potent form of skin inflammation
associated with an elevated level of IgE and the activa-
tion of IL-1β [34–36]. In this study, we mainly focused
on the regulation of ID on proinflammatory cytokines
but not Th2 cytokines, since it has been reported that
the inhibitory effect of ID on DSS-induced colitis is
due to the reduction of proinflammatory cytokines in-
cluding TNF-α and IL-6 in previous study [8]. There-
fore, we repeated the application of DNFB to induce
AD-like lesions in BALB/c mice and investigated an
Fig. 4 Effects of ID on the production of proinflammatory cytokines and the activation of MAPKs and NF-κB in HMC-1 cells. (a) HMC-1 cells
(1 × 104 cells/well) were treated with ID (0.01 - 1 mg/ml) for 24 h and the cell viability was analyzed with MTT assays. (b-d) The production levels
of TNF-α (B), IL-8 (c), and IL-6 (d) were measured using the ELISA method. HMC-1 cells (2 × 105 cells/well) were pre-treated with ID for 1 h and
were stimulated with PMA (50 nM) + A23187 (1 μM) for 8 h. Values represent the mean ± SD of three independent experiments. *p < 0.05, **
p < 0.01, ***p < 0.001. (e and f) Phosphorylation of p38, ERK and JNK (e) and the phosphorylation of IκBα and translocation of NF-κB (f) were
assayed by western blot analysis. HMC-1 cells (1 × 106 cells/well) were incubated with various concentrations of ID and then stimulated with PMA
(50 nM) + A23187 (1 μM) for 30 min (e) or 2 h (f). C, cytosol extracts; N, nuclear extracts
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effect of ID treatment. ID significantly reduced DNFB-
induced dermatitis and decreased the serum levels of
IgE and the IL-1β via the inhibition of p38, ERK, and
JNK phosphorylation as well as the activation of NF-κB
in AD-like skin lesions (Fig. 1 and 2). Compound 48/
80, one of the most potent secretagogues, increases the
permeability of the lipid bilayer membrane by causing a
perturbation in the membrane upon mast cell degranu-
lation [37]. ID administration also inhibited compound
48/80-induced anaphylactic shock in dose-dependent
manner (Table 2). These results indicate that ID has a
potent effect on anti-allergic responses in mice model.
HaCaT cells, a spontaneously transformed human
keratinocyte cell line, are commonly used in pharmaco-
logical studies of skin diseases such as dermatitis, as it
produces proinflammatory cytokines and chemokines
upon various types of stimulation. HaCaT cells develop
skin-associated lymphoid tissue by increasing the levels
of surface antigens and interacting with other immuno-
cytes [38]. TARC and MDC, typical Th2 chemokines,
Fig. 5 Effects of caffeic acid on the production of proinflammatory cytokines and the activation of MAPKs and NF-κB in HMC-1 cells. (a) HMC-1 cells
(1 × 104 cells/well) were treated with caffeic acid (1–100 μM) for 24 h and the degree of cell viability was analyzed with MTT assays. (b-d) The
production levels of TNF-α (b), IL-8 (c), and IL-6 (d) were measured using the ELISA method. HMC-1 cells (2 × 105 cells/well) were pre-treated with
caffeic acid for 1 h and were stimulated with PMA (50 nM) + A23187 (1 μM) for 8 h. Values represent the mean ± SD of three independent experiments.
*p < 0.05, **p < 0.01, ***p< 0.001. (e and f) Phosphorylation of p38, ERK and JNK (e) and the degradation of IκBα and translocation of NF-κB (f) were
assayed by western blot analysis. HMC-1 cells (1 × 106 cells/well) were incubated with various concentrations of caffeic acid and then stimulated with
PMA (50 nM) + A23187 (1 μM) for 30 min (e) or 2 h (f). C, cytosol extracts; N, nuclear extracts
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are both induced in HaCaT cells upon stimulation with
IFN-γ and TNF-α [39]. As the chemokine, IL-8 plays a
role in the activation of inflammatory effector cells such as
neutrophils, T-lymphocytes, and eosinophils [40]. In this
study, ID inhibited the mRNA expression of chemokines
(IL-8, TARC, and MDC), and the adhesion molecule
(ICAM-1), and MMP-9. Caffeic acid also reduced the ex-
pressions of IL-8 and TARC in TNF-α/IFN-γ-stimulated
HaCaT cells (Fig. 3).
Mast cells play an important role in both adaptive and
innate immunity and show increases in immunological
skin diseases, including dermatitis [41]. The HMC-1 cell
line was established from leukemia patients; it expresses
characteristic markers for mast cells [42]. In response to
different types of stimulation, mast cells release an array
of cytokines, especially TNF-α, IL-6, and IL-8, with the
potential to cause inflammation [18]. Therefore, the in-
hibition of cytokine secretion can be a useful therapeutic
strategy for allergic inflammatory diseases such as AD.
In this study, we demonstrated that ID and caffeic acid
decreased the production of TNF-α and IL-8 in PMA +
A23187-stimulated HMC-1 cells (Fig. 4 and 5). The ex-
pressions of proinflammatory cytokines such as TNF-α,
IL-6, and IL-8 are associated with the activation of
MAPKs and transcription factor NF-κB [25, 26]. To elu-
cidate the mechanisms of the ID-mediated inhibition of
proinflammatory cytokine production, we examined the
regulatory effect of ID on the intracellular signaling mol-
ecules involved in the PMA + A23187-induced signaling
pathways. ID decreases the nuclear translocation of NF-
κB via the p38 and ERK, whereas caffeic acid regulates
the phosphorylation of p38 but not ERK or JNK (Fig. 4
and 5). These results demonstrate that ID and caffeic
acid suppress the production of proinflammatory cyto-
kines through the phosphorylation of MAPKs and the
activation of the NF-κB pathway. In contrast, we were
unable to find the inhibitory effect of ID and caffeic acid
on IL-6 production. Other studies demonstrated that IL-6
production is regulated by JNK activation in renal epithe-
lial cells and PMA-stimulated Jurkat T cells [43, 44]. Since
the drugs might not affect JNK activation, consequently
both drugs did not decrease the IL-6 production.
In a previous study, we found that ID contained ap-
proximately 4 mg/g of caffeic acid (3,4-dihydroxy cinamic
acid) [8]. Approximately 20 types of sesquiterpene and
other compounds have been isolated from ID. It has been
reported that its main compounds are luteolin, luteolin 7-
O-glucuronide, caffeic acid, chlorogenic acid, and guaiane
sesquiterpene lactones [45, 46]. Among these main com-
pounds, inhibitory effects of luteolin, chlorogenic acid,
and tectroside on allergic inflammation had already been
reported [9, 47–49]. Thus, we focused on ID and caffeic
acid and demonstrated both drugs’ anti-allergic inflamma-
tory effect on HaCaT and HMC-1 cells. Caffeic acid was
effective for reducing inflammatory responses with regard
to TPA-induced ear thickness, and TPA/calcium iono-
phore or TNF-α-stimulated HaCaT cells [50, 51].
Therefore, caffeic acid may be partly responsible for the
anti-allergic effect of ID. Indeed, we showed in present
study that caffeic acid reduced the expressions of IL-8
and TARC as well as p38/NF-κB pathway in TNF-α/
IFN-γ-stimulated HaCaT cells and HMC-1 cells.
In this study, ID decreased the production of proin-
flammatory cytokines including TNF-α and IL-8 in mast
cells and inhibited TNF-α/IFN-γ-induced expression of
chemokines such as IL-8, TARC and MDC in HaCaT
cells. We showed that ID also reduced the expression of
MMP-9, which is induced by histamine in keratinocyte
[52]. Yi et al. [10] reported that ID inhibited the hista-
mine release in mast cells. Therefore we suggest that re-
duced MMP-9 expression in keratinocytes by ID may be
due to inhibition of ID on histamine release. These re-
sponses might also be occurred via blockage of the p38
and ERK/NF-κB pathway in mast cells and keratinocytes
by ID treatment. In addition, MAPKs/NF-κB activation
was inhibited by ID administration in AD-like skin le-
sion mice model. Consequently, ID water extract can
improve the allergic inflammatory diseases through in-
hibition of proinflammatory cytokines, chemokines, and
MMP-9 by regulation of MAPKs/NF-κB pathway in
mast cells and keratinocytes.
Conclusions
Our data suggest that ID can be used in the treatment
of allergic skin diseases, including AD. ID showed anti-
inflammatory and anti-allergic activities by suppressing
skin dermatitis in DNFB-sensitized mice and compound
48/80-induced systemic anaphylaxis through the inhib-
ition of serum IgE and IL-1β release. In addition, ID
inhibited the TNF-α/IFN-γ-induced expression of che-
mokines (IL-8, TARC, and MDC), ICAM-1, and MMP-9
in keratinocytes. Moreover, ID reduced proinflammatory
cytokines (TNF-α and IL-8) via the blockage of p38/ERK
phosphorylation and NF-κB activation in mast cells.
These results lend insight into the pharmacological ac-
tions of ID as a potential therapy for allergic inflamma-
tory diseases such as dermatitis.
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